In the News, Breaking New Ground, Not as Expected, Small Wonders
Jack of All Trades Today the US Food and Drug Administration (FDA) approved two gene-based treatments for sickle cell disease, Casgevy and Lyfgenia, a genetic disease that can cause extreme pain and reduces average life…